Teladoc, Inc. (NYSE:TDOC)’s share price gapped down prior to trading on Wednesday . The stock had previously closed at $37.85, but opened at $36.75. Teladoc shares last traded at $35.55, with a volume of 2510261 shares trading hands.

Several research firms recently issued reports on TDOC. BidaskClub upgraded shares of Teladoc from a “sell” rating to a “hold” rating in a research note on Wednesday, August 9th. Cowen reiterated an “outperform” rating and issued a $39.00 target price on shares of Teladoc in a research note on Saturday, September 30th. Piper Jaffray Companies reissued a “buy” rating and issued a $42.00 price target on shares of Teladoc in a report on Friday, September 29th. Cantor Fitzgerald reissued a “hold” rating and issued a $31.00 price target on shares of Teladoc in a report on Tuesday, September 26th. Finally, Oppenheimer boosted their price target on shares of Teladoc from $40.00 to $45.00 and gave the stock an “outperform” rating in a report on Tuesday, November 21st. One research analyst has rated the stock with a sell rating, four have given a hold rating and nine have given a buy rating to the company. Teladoc presently has a consensus rating of “Buy” and a consensus price target of $39.00.

The company has a debt-to-equity ratio of 0.83, a quick ratio of 5.08 and a current ratio of 5.08.

Teladoc (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, November 1st. The health services provider reported ($0.55) EPS for the quarter, missing the consensus estimate of ($0.30) by ($0.25). The company had revenue of $68.70 million during the quarter, compared to analysts’ expectations of $67.53 million. Teladoc had a negative return on equity of 21.59% and a negative net margin of 39.61%. Teladoc’s revenue was up 112.0% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.33) EPS. equities analysts forecast that Teladoc, Inc. will post -1.57 EPS for the current year.

In other news, VP Mark Hirschhorn sold 10,000 shares of the company’s stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $34.04, for a total transaction of $340,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jason N. Gorevic sold 20,000 shares of the company’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $32.10, for a total transaction of $642,000.00. Following the sale, the chief executive officer now directly owns 838,261 shares of the company’s stock, valued at approximately $26,908,178.10. The disclosure for this sale can be found here. Insiders have sold 135,000 shares of company stock valued at $4,408,700 in the last ninety days. Insiders own 4.47% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in TDOC. Teachers Advisors LLC boosted its position in shares of Teladoc by 53.6% during the 1st quarter. Teachers Advisors LLC now owns 54,067 shares of the health services provider’s stock valued at $1,352,000 after acquiring an additional 18,862 shares during the last quarter. TIAA CREF Investment Management LLC boosted its position in shares of Teladoc by 57.6% during the 1st quarter. TIAA CREF Investment Management LLC now owns 95,302 shares of the health services provider’s stock valued at $2,383,000 after acquiring an additional 34,833 shares during the last quarter. Legal & General Group Plc boosted its position in shares of Teladoc by 66.3% during the 1st quarter. Legal & General Group Plc now owns 6,137 shares of the health services provider’s stock valued at $154,000 after acquiring an additional 2,446 shares during the last quarter. Vanguard Group Inc. boosted its position in shares of Teladoc by 50.0% during the 1st quarter. Vanguard Group Inc. now owns 2,727,079 shares of the health services provider’s stock valued at $68,177,000 after acquiring an additional 909,252 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of Teladoc by 77.8% during the 1st quarter. Geode Capital Management LLC now owns 254,130 shares of the health services provider’s stock valued at $6,353,000 after acquiring an additional 111,187 shares during the last quarter.

TRADEMARK VIOLATION WARNING: This report was originally posted by Daily Political and is the property of of Daily Political. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at https://www.dailypolitical.com/2017/11/30/teladoc-tdoc-shares-gap-down-to-36-75.html.

Teladoc Company Profile

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Receive News & Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related companies with MarketBeat.com's FREE daily email newsletter.